Literature DB >> 8690798

Vascular dysfunction in monkeys with diet-induced hyperhomocyst(e)inemia.

S R Lentz1, C G Sobey, D J Piegors, M Y Bhopatkar, F M Faraci, M R Malinow, D D Heistad.   

Abstract

Elevated plasma homocyst(e)ine may predispose to complications of vascular disease. Homocysteine alters vasomotor regulatory and anticoagulant properties of cultured vascular endothelial cells, but little is known about effects of hyperhomocyst(e)inemia on vascular function in vivo. We tested the hypothesis that diet-induced moderate hyperhomocyst(e)inemia is associated with vascular dysfunction in cynomolgus monkeys. Plasma homocyst(e)ine increased from 4.O +/- O.2 microM when monkeys were fed normal diet to 10.6 +/- 2.6 microM when they were fed modified diet (mean +/- SE; P = 0.02). Vasomotor responses were assessed in vivo by quantitative angiography and Doppler measurement of blood flow velocity. In response to activation of platelets by intraarterial infusion of collagen, blood flow to the leg decreased by 42 +/- 9% in monkeys fed modified diet, compared with 14 +/- 11% in monkeys fed normal diet (P = 0.008), Responses of resistance vessels to the endothelium-dependent vasodilators acetylcholine and ADP were markedly impaired in hyperhomocyst(e)inemic monkeys, which suggests that increased vasoconstriction in response to collagen may be caused by decreased vasodilator responsiveness to platelet-generated ADP. Relaxation to acetylcholine and, to a lesser extent, nitroprusside, was impaired ex vivo in carotid arteries from monkeys fed modified diet. Thrombomodulin anticoagulant activity in aorta decreased by 34 +/- 15% in hyperhomocyst(e)inemic monkeys (P = 0.03). We conclude that diet-induced moderate hyperhomocyst(e)inemia is associated with altered vascular function.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8690798      PMCID: PMC507396          DOI: 10.1172/JCI118771

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  30 in total

1.  [Rapid physiological coagulation method in determination of fibrinogen].

Authors:  A CLAUSS
Journal:  Acta Haematol       Date:  1957-04       Impact factor: 2.195

2.  Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries.

Authors:  P L Ludmer; A P Selwyn; T L Shook; R R Wayne; G H Mudge; R W Alexander; P Ganz
Journal:  N Engl J Med       Date:  1986-10-23       Impact factor: 91.245

3.  Plasma homocyst(e)ine or homocysteine?

Authors:  S H Mudd; H L Levy
Journal:  N Engl J Med       Date:  1995-08-03       Impact factor: 91.245

4.  Atherosclerosis impairs endothelium-dependent vascular relaxation to acetylcholine and thrombin in primates.

Authors:  P C Freiman; G G Mitchell; D D Heistad; M L Armstrong; D G Harrison
Journal:  Circ Res       Date:  1986-06       Impact factor: 17.367

5.  Aggregating human platelets cause direct contraction and endothelium-dependent relaxation of isolated canine coronary arteries. Role of serotonin, thromboxane A2, and adenine nucleotides.

Authors:  D S Houston; J T Shepherd; P M Vanhoutte
Journal:  J Clin Invest       Date:  1986-08       Impact factor: 14.808

6.  Speculation regarding mechanisms responsible for acute ischemic heart disease syndromes.

Authors:  J T Willerson; L D Hillis; M Winniford; L M Buja
Journal:  J Am Coll Cardiol       Date:  1986-07       Impact factor: 24.094

7.  Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activator.

Authors:  G M Rodgers; W H Kane
Journal:  J Clin Invest       Date:  1986-06       Impact factor: 14.808

8.  Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine.

Authors:  G Starkebaum; J M Harlan
Journal:  J Clin Invest       Date:  1986-04       Impact factor: 14.808

9.  The natural history of homocystinuria due to cystathionine beta-synthase deficiency.

Authors:  S H Mudd; F Skovby; H L Levy; K D Pettigrew; B Wilcken; R E Pyeritz; G Andria; G H Boers; I L Bromberg; R Cerone
Journal:  Am J Hum Genet       Date:  1985-01       Impact factor: 11.025

10.  A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes.

Authors:  C J Boushey; S A Beresford; G S Omenn; A G Motulsky
Journal:  JAMA       Date:  1995-10-04       Impact factor: 56.272

View more
  61 in total

Review 1.  Homocysteine: a sulph'rous fire.

Authors:  K A Hajjar
Journal:  J Clin Invest       Date:  2001-03       Impact factor: 14.808

2.  Hyperhomocysteinemia and function of the endoplasmic reticulum.

Authors:  D Ron
Journal:  J Clin Invest       Date:  2001-05       Impact factor: 14.808

Review 3.  Homocyst(e)ine and coronary heart disease: pharmacoeconomic support for interventions to lower hyperhomocyst(e)inaemia.

Authors:  Brahmajee K Nallamothu; A Mark Fendrick; Gilbert S Omenn
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

4.  Cyclin A transcriptional suppression is the major mechanism mediating homocysteine-induced endothelial cell growth inhibition.

Authors:  Hong Wang; XiaoHua Jiang; Fan Yang; Gary B Chapman; William Durante; Nicholas E S Sibinga; Andrew I Schafer
Journal:  Blood       Date:  2002-02-01       Impact factor: 22.113

Review 5.  Disorders of homocysteine metabolism.

Authors:  B Fowler
Journal:  J Inherit Metab Dis       Date:  1997-06       Impact factor: 4.982

Review 6.  Atherosclerotic vascular disease: will folate or gene therapy be useful?

Authors:  D D Heistad; S R Lentz; C D Rios
Journal:  Trans Am Clin Climatol Assoc       Date:  1997

7.  Overexpression of cellular glutathione peroxidase rescues homocyst(e)ine-induced endothelial dysfunction.

Authors:  N Weiss; Y Y Zhang; S Heydrick; C Bierl; J Loscalzo
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-16       Impact factor: 11.205

Review 8.  Alzheimer's disease: cerebrovascular dysfunction, oxidative stress, and advanced clinical therapies.

Authors:  Michael W Marlatt; Paul J Lucassen; George Perry; Mark A Smith; Xiongwei Zhu
Journal:  J Alzheimers Dis       Date:  2008-10       Impact factor: 4.472

9.  Overexpression of dimethylarginine dimethylaminohydrolase protects against cerebral vascular effects of hyperhomocysteinemia.

Authors:  Roman N Rodionov; Hayan Dayoub; Cynthia M Lynch; Katina M Wilson; Jeff W Stevens; Daryl J Murry; Masumi Kimoto; Erland Arning; Teodoro Bottiglieri; John P Cooke; Gary L Baumbach; Frank M Faraci; Steven R Lentz
Journal:  Circ Res       Date:  2009-12-17       Impact factor: 17.367

Review 10.  Homocysteine, MTHFR gene polymorphisms, and cardio-cerebrovascular risk.

Authors:  Elisabetta Trabetti
Journal:  J Appl Genet       Date:  2008       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.